Alvotech Quarterly Balance Sheet
NASDAQ: ALVOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Alvotech financial position
As of Dec 31, 2025, Alvotech reported total assets of $1.49 billion, up 148.7% from a year earlier against total liabilities of $1.77 billion. Shareholders' equity was negative at -$284.5 million, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $172.4 million in cash and equivalents against $1.30 billion of debt, a net debt position of $1.13 billion.
The current ratio (current assets divided by current liabilities) was 1.89, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Alvotech balance sheet (quarterly)
| Quarter (USD) | Q4 20252025-12-31 | Q4 20242024-12-31 | Q4 20232023-12-31 | Q4 20222022-12-31 | Q4 20212021-12-31 |
|---|---|---|---|---|---|
| Cash & Equivalents | 172.36M | 51.43M | 11.16M | 66.43M | 17.56M |
| Inventory | 220.05M | 127.89M | 74.43M | 71.47M | 39.06M |
| Total Current Assets | 574.01M | 455.02M | 194.84M | 230.74M | 119.82M |
| Property, Plant & Equipment | 356.40M | 284.55M | 236.78M | 220.59M | 78.53M |
| Goodwill | 12.84M | 11.33M | 12.06M | 11.64M | 12.37M |
| Intangible Assets | 81.83M | 20.62M | 19.08M | 25.65M | 21.51M |
| Total Assets | 1.49B | 1.22B | 950.09M | 828.44M | 597.98M |
| Accounts Payable | 126.12M | 67.13M | 80.56M | 49.19M | 28.59M |
| Short-Term Debt | 36.92M | 32.70M | 38.02M | 19.92M | 2.77M |
| Total Current Liabilities | 304.08M | 193.40M | 260.95M | 167.29M | 111.84M |
| Long-Term Debt | 1.26B | 1.04B | 922.13M | 744.65M | 398.14M |
| Total Liabilities | 1.77B | 1.63B | 1.88B | 1.39B | 733.59M |
| Shareholders' Equity | -284.49M | -412.77M | -932.49M | -564.42M | -135.61M |
| Retained Earnings | -2.41B | -2.44B | -2.21B | -1.65B | -1.14B |
| Total Debt | 1.30B | 1.07B | 960.16M | 764.57M | 400.91M |
| Net Cash (Debt) | -1.13B | -1.02B | -949.00M | -698.14M | -383.36M |
| Shares Outstanding | 312.02M | 301.81M | 266.82M | 252.16M | 893.06K |
This table shows 5 quarterly periods of Alvotech's balance sheet, from Q4 2025 back to Q4 2021, across 17 line items including cash & equivalents, inventory, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow ALVO's reporting calendar. What is a balance sheet?